LONDON (Thomson Financial) - Imperial Innovations Group PLC, investment fund Longbow Capital and venture capital fund The Capital Fund, said in a joint statement that they have invested 2.3 mln stg in PolyTherics Ltd, an innovative biopharmaceutical company.
